Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development

World Journal of Gastroenterology

Volumn 19, Issue 7, 2013, Pages 984-993

  Chung, Min Yu ^a   Lim, Tae Gyu ^b   Lee, Ki Won ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

( ) epigallocatechin gallate; Curcumin; Gastroenterological cancers; Isothiocyanates; Molecular target; Resveratrol; Sulforaphane

Indexed keywords

BETA CATENIN; CURCUMIN; CYCLIN D1; CYCLOOXYGENASE 2; DNA METHYLTRANSFERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GALLOCATECHIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; ISOTHIOCYANIC ACID DERIVATIVE; LYMPHOID ENHANCER FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; P21 ACTIVATED KINASE; PHENETHYL ISOTHIOCYANATE; PLANT MEDICINAL PRODUCT; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; RESVERATROL; STRESS ACTIVATED PROTEIN KINASE; SULFORAPHANE; SUPEROXIDE DISMUTASE; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COLON CANCER; COLORECTAL CANCER; DIET; DIGESTIVE SYSTEM TUMOR; DNA ADDUCT; DNA METHYLATION; DRUG MECHANISM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; HUMAN; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); SIGNAL TRANSDUCTION; STOMACH CANCER;

EID: 84874349469     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i7.984     Document Type: Article

References (110)

1. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992; 18: 1-29 [PMID: 1408943 DOI: 10.1080/0163558 9209514201]
2. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454-457 [PMID: 8094487 DOI: 10.1016/0140-6736(93)90206-V]
3. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526 [PMID: 1351198 DOI: 10.1016/0140-6736(92)91277-F]
4. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 1991; 2: 325-357 [PMID: 1834240 DOI: 10.1007/BF00051672]
5. Lee KW, Bode AM, Dong Z. Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 2011; 11: 211-218 [PMID: 21326325 DOI: 10.1038/nrc3017]
6. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 [PMID: 15761078 DOI: 10.3322/canjclin.55.2.74]
7. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cacer statistics, 2007. CA Cancer J Clin 2005; 57: 43-66 [PMID: 17237035 DOI: 10.3322/canjclin.57.1.43]
8. Subramaniam D, Ponnurangam S, Ramamoorthy P, Standing D, Battafarano RJ, Anant S, Sharma P. Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One 2012; 7: e30590 [PMID: 22363450 DOI: 10.1371/journal.pone.0030590]
9. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, Grosclaude P, Hédelin G, Matsuda T, Møller H, Möller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D. EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol 2003; 14 Suppl 5: v61-118 [PMID: 14684501 DOI: 10.1093/annonc/mdg754]
10. Wynder EL, BROSS IJ. A study of etiological factors in cancer of the esophagus. Cancer 1961; 14: 389-413 [PMID: 13786981 DOI: 10.1002/1097-0142(196103/04)14]
11. Stoner GD, Kresty LA, Carlton PS, Siglin JC, Morse MA. Isothiocyanates and freeze-dried strawberries as inhibitors of esophageal cancer. Toxicol Sci 1999; 52: 95-100 [PMID: 10630596]
12. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JF. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95: 1404-1413 [PMID: 13130116 DOI: 10.1093/jnci/djg047]
13. Stoner GD, Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 2001; 22: 1737-1746 [PMID: 11698334 DOI: 10.1093/carcin/22.11.1737]
14. VanEtten CH, Daxenbichler ME, Williams PH, Kwolek WF. Glucosinolates and derived products in cruciferous vegetables. Analysis of the edible part from twenty-two varieties of cabbage. J Agric Food Chem 1976; 24: 452-455 [PMID: 1270657 DOI: 10.1021/jf60205a049]
15. Eklind KI, Morse MA, Chung FL. Distribution and metabolism of the natural anticarcinogen phenethyl isothiocya nate in A/J mice. Carcinogenesis 1990; 11: 2033-2036 [PMID: 2225337 DOI: 10.1093/carcin/11.11.2033]
16. Wilkinson JT, Morse MA, Kresty LA, Stoner GD. Effect of alkyl chain length on inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis and DNA methylation by isothiocyanates. Carcinogenesis 1995; 16: 1011-1015 [PMID: 7767958 DOI: 10.1093/carcin/16.5.1011]
17. Morse MA, Lu J, Gopalakrishnan R, Peterson LA, D'Ambrosio SM, Wani G, Stoner GD. Mechanism of enhancement of esophageal tumorigenesis by 6-phenylhexyl isothiocyanate. Cancer Lett 1997; 112: 119-125 [PMID: 9029177 DOI: 10.1016/S0304-3835(96)04556-9]
18. Stoner GD, Morse MA. Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer. Cancer Lett 1997; 114: 113-119 [PMID: 9103268 DOI: 10.1016/S0304-3835 (97)04639-9]
19. Weisburger JH. Mechanisms of action of antioxidants as exemplified in vegetables, tomatoes and tea. Food Chem Toxicol 1999; 37: 943-948 [PMID: 10541449 DOI: 10.1016/ S0278-6915(99)00086-1]
20. Wang ZY, Wang LD, Lee MJ, Ho CT, Huang MT, Conney AH, Yang CS. Inhibition of N-nitrosomethylbenzylamineinduced esophageal tumorigenesis in rats by green and black tea. Carcinogenesis 1995; 16: 2143-2148 [PMID: 7554067 DOI: 10.1093/carcin/16.9.2143]
21. Chen J. The effects of Chinese tea on the occurrence of esophageal tumors induced by N-nitrosomethylbenzylamine in rats. Prev Med 1992; 21: 385-391 [PMID: 1615000 DOI: 10.1016/0091-7435(92)90046-K]
22. Chung JY, Huang C, Meng X, Dong Z, Yang CS. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res 1999; 59: 4610-4617 [PMID: 10493515]
23. Chung JY, Park JO, Phyu H, Dong Z, Yang CS. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3'-digallate. FASEB J 2001; 15: 2022-2024 [PMID: 11511526 DOI: 10.1096/fj.01-0031fje01-0031fje]
24. Dong Z, Ma W, Huang C, Yang CS. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 1997; 57: 4414-4419 [PMID: 9331105]
25. Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 2005; 11: 2735-2746 [PMID: 15814656 DOI:10.1158/1078-0432.CCR-04-2014]
26. Ahmad N, Cheng P, Mukhtar H. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 2000; 275: 328-334 [PMID: 10964666 DOI: 10.1006/bbrc.2000.3297]
27. Gupta S, Hussain T, Mukhtar H. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 2003; 410: 177-185 [PMID: 12559991 DOI: 10.1016/ S0003-9861(02)00668-9]
28. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997; 89: 1881-1886 [PMID: 9414176 DOI: 10.1093/jnci/89.24.1881]
29. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003; 63: 7563-7570 [PMID: 14633667]
30. Ye F, Zhang GH, Guan BX, Xu XC. Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocate-chin-3-gallate and lovastatin. World J Gastroenterol 2012; 18: 126-135 [PMID: 22253518 DOI: 10.3748/wjg.v18.i2.126]
31. Hou Z, Sang S, You H, Lee MJ, Hong J, Chin KV, Yang CS. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res 2005; 65: 8049-8056 [PMID: 16140980]
32. Li ZG, Shimada Y, Sato F, Maeda M, Itami A, Kaganoi J, Komoto I, Kawabe A, Imamura M. Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamineinduced esophageal tumorigenesis in F344 rats. Int J Oncol 2002; 21: 1275-1283 [PMID: 12429978]
33. Li ZG, Shimada Y, Sato F, Maeda M, Itami A, Kaganoi J, Komoto I, Kawabe A, Imamura M. Promotion effects of hot water on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats. Oncol Rep 2003; 10: 421-426 [PMID: 12579283]
34. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002; 21: 5427-5440 [PMID: 12154405 DOI: 10.1038/ sj.onc.1205600]
35. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428 [PMID: 12042769 DOI: 10.1038/nrg816nrg816]
36. Lichtenstein AV, Kisseljova NP. DNA methylation and carcinogenesis. Biochemistry (Mosc) 2001; 66: 235-255 [PMID: 11333147]
37. Nguyen CT, Gonzales FA, Jones PA. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res 2001; 29: 4598-4606 [PMID: 11713309 DOI: 10.1093/nar/29.22.4598]
38. Rice JC, Massey-Brown KS, Futscher BW. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene 1998; 17: 1807-1812 [PMID: 9778046 DOI: 10.1038/ sj.onc.1202086]
39. Bender CM, Pao MM, Jones PA. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 1998; 58: 95-101 [PMID: 9426064]
40. Cheng JC, Matsen CB, Gonzales FA, Ye W, Greer S, Marquez VE, Jones PA, Selker EU. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst 2003; 95: 399-409 [PMID: 12618505 DOI: 10.1093/ jnci/95.5.399]
41. Christman JK. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 2002; 21: 5483-5495 [PMID: 12154409 DOI: 10.1038/sj.onc.1205699]
42. Zhou L, Cheng X, Connolly BA, Dickman MJ, Hurd PJ, Hornby DP. Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J Mol Biol 2002; 321: 591-599 [PMID: 12206775 DOI: 10.1016/S0022-2836(02)00676-9]
43. Esatbeyoglu T, Huebbe P, Ernst IM, Chin D, Wagner AE, Rimbach G. Curcumin--from molecule to biological function. Angew Chem Int Ed Engl 2012; 51: 5308-5332 [PMID: 22566109 DOI: 10.1002/anie.201107724]
44. Goel A, Aggarwal BB. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 2010; 62: 919-930 [PMID: 20924967 DOI: 10.1080/01635581.2010.509835]
45. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160: 1-40 [PMID: 16430879 DOI: 10.1016/j.cbi.2005.12.009]
46. Bower MR, Aiyer HS, Li Y, Martin RC. Chemoprotective effects of curcumin in esophageal epithelial cells exposed to bile acids. World J Gastroenterol 2010; 16: 4152-4158 [PMID: 20806431 DOI: 10.3748/wjg.v16.i33.4152]
47. Rayet B, Gélinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999; 18: 6938-6947 [PMID: 10602468 DOI: 10.1038/sj.onc.1203221]
48. Arlt A, Gehrz A, Müerköster S, Vorndamm J, Kruse ML, Fölsch UR, Schäfer H. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 2003; 22: 3243-3251 [PMID: 12761494 DOI: 10.1038/sj.onc.1206390]
49. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 2007; 67: 3853-3861 [PMID: 17440100 DOI: 10.1158/0008-5472.CAN-06-4257]
50. Hartojo W, Silvers AL, Thomas DG, Seder CW, Lin L, Rao H, Wang Z, Greenson JK, Giordano TJ, Orringer MB, Rehemtulla A, Bhojani MS, Beer DG, Chang AC. Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. Transl Oncol 2010; 3: 99-108 [PMID: 20360934]
51. Tian F, Song M, Xu PR, Liu HT, Xue LX. [Curcumin promotes apoptosis of esophageal squamous carcinoma cell lines through inhibition of NF-kappaB signaling pathway]. Ai Zheng 2008; 27: 566-570 [PMID: 18570726]
52. Rawat N, Alhamdani A, McAdam E, Cronin J, Eltahir Z, Lewis P, Griffiths P, Baxter JN, Jenkins GJ. Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett' s oesophagus. Clin Transl Oncol 2012; 14: 302-311 [PMID: 22484638 DOI: 10.1007/s12094-012-0799-x]
53. Masuda S. Dysfunctional transforming growth factor-β signaling with constitutively active notch signaling in Barrett' s esophageal adenocarcinoma. Cancer 2012; 118: 1956-1957; author reply 1957-1958 [PMID: 21898377 DOI: 10.1002/ cncr.26444]
54. Mendelson J, Song S, Li Y, Maru DM, Mishra B, Davila M, Hofstetter WL, Mishra L. Dysfunctional transforming growth factor-β signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma. Cancer 2011; 117: 3691-3702 [PMID: 21305538 DOI: 10.1002/ cncr.25861]
55. Peters JH, Avisar N. The molecular pathogenesis of Barrett' s esophagus: common signaling pathways in embryogenesis metaplasia and neoplasia. J Gastrointest Surg 2010; 14 Suppl 1: S81-S87 [PMID: 19760304 DOI: 10.1007/s11605-009-1011-7]
56. Woo SM, Kim J, Han HW, Chae JI, Son MY, Cho S, Chung HM, Han YM, Kang YK. Notch signaling is required for maintaining stem-cell features of neuroprogenitor cells derived from human embryonic stem cells. BMC Neurosci 2009; 10: 97 [PMID: 19682396 DOI: 10.1186/1471-2202-10-97]
57. Liao S, Xia J, Chen Z, Zhang S, Ahmad A, Miele L, Sarkar FH, Wang Z. Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways. J Cell Biochem 2011; 112: 1055-1065 [PMID: 21308734 DOI: 10.1002/jcb.23019]
58. Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 1999; 13 Suppl 1: 3-11 [PMID: 10209681 DOI: 10.1046/ j.1365-2036.1999.00002.x]
59. Yanaka A. Sulforaphane enhances protection and repair of gastric mucosa against oxidative stress in vitro, and demonstrates anti-inflammatory effects on Helicobacter pyloriinfected gastric mucosae in mice and human subjects. Curr Pharm Des 2011; 17: 1532-1540 [PMID: 21548875 DOI: 10.217 4/138161211796196945]
60. De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair GB, Mukhopadhyay AK. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 2009; 53: 1592-1597 [PMID: 19204190 DOI: 10.1128/ AAC.01242-08]
61. Yu LL, Wu JG, Dai N, Yu HG, Si JM. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor. Oncol Rep 2011; 26: 1197-1203 [PMID: 21811763 DOI: 10.3892/or.2011.1410]
62. Cai XZ, Wang J, Li XD, Wang GL, Liu FN, Cheng MS, Li F. Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol Ther 2009; 8: 1360-1368 [PMID: 19448398 DOI: 10.4161/cbt.8.14.8720]
63. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol 1998; 138: 619-620 [PMID: 9678525 DOI: 10.1530/eje.0.1380619]
64. Sun AY, Simonyi A, Sun GY. The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic Biol Med 2002; 32: 314-318 [PMID: 11841921 DOI: 10.1016/ S0891-5849(01)00803-6]
65. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ. Cardio-protective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 2000; 47: 549-555 [PMID: 10963727 DOI: 10.1016/S0008-6363(00)00102-4]
66. Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French paradox revisited. Front Pharmacol 2012; 3: 141 [PMID: 22822401 DOI: 10.3389/fphar.2012.00141]
67. Chan MM. Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem Pharmacol 2002; 63: 99-104 [PMID: 11841782 DOI: 10.1016/ S0006-2952(01)00886-3]
68. Daroch F, Hoeneisen M, González CL, Kawaguchi F, Salgado F, Solar H, García A. In vitro antibacterial activity of Chilean red wines against Helicobacter pylori. Microbios 2001; 104: 79-85 [PMID: 11297014]
69. Mahady GB, Pendland SL. Resveratrol inhibits the growth of Helicobacter pylori in vitro. Am J Gastroenterol 2000; 95: 1849 [PMID: 10926010]
70. Mahady GB, Pendland SL, Chadwick LR. Resveratrol and red wine extracts inhibit the growth of CagA+ strains of Helicobacter pylori in vitro. Am J Gastroenterol 2003; 98: 1440-1441 [PMID: 12818294 DOI: 10.1111/j.1572-0241.2003.07513.x]
71. Zaidi SF, Ahmed K, Yamamoto T, Kondo T, Usmanghani K, Kadowaki M, Sugiyama T. Effect of resveratrol on Helicobacter pylori-induced interleukin-8 secretion, reactive oxygen species generation and morphological changes in human gastric epithelial cells. Biol Pharm Bull 2009; 32: 1931-1935 [PMID: 19881312 DOI: 10.1248/bpb.32.1931]
72. Atten MJ, Attar BM, Milson T, Holian O. Resveratrol induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism. Biochem Pharmacol 2001; 62: 1423-1432 [PMID: 11709203 DOI:10.1016/S0006-2952(01)00788-2]
73. Atten MJ, Godoy-Romero E, Attar BM, Milson T, Zopel M, Holian O. Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells. Invest New Drugs 2005; 23: 111-119 [PMID: 15744586 DOI: 10.1007/s10637-005-5855-8]
74. Aquilano K, Baldelli S, Rotilio G, Ciriolo MR. trans-Resveratrol inhibits H2O2-induced adenocarcinoma gastric cells proliferation via inactivation of MEK1/2-ERK1/2-c-Jun signalling axis. Biochem Pharmacol 2009; 77: 337-347 [PMID: 19038233 DOI: 10.1016/j.bcp.2008.10.034]
75. Wang Z, Li W, Meng X, Jia B. Resveratrol induces gastric cancer cell apoptosis via reactive oxygen species, but independent of sirtuin1. Clin Exp Pharmacol Physiol 2012; 39: 227-232 [PMID: 22211760 DOI: 10.1111/j.1440-1681.2011.05660.x]
76. Zhou HB, Yan Y, Sun YN, Zhu JR. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J Gastroenterol 2003; 9: 408-411 [PMID: 12632486]
77. Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 2005; 11: 280-284 [PMID: 15633232]
78. Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, Talalay P, Lozniewski A. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyreneinduced stomach tumors. Proc Natl Acad Sci USA 2002; 99: 7610-7615 [PMID: 12032331 DOI: 10.1073/pnas.112203099]
79. Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA 1997; 94: 10367-10372 [PMID: 9294217 DOI: 10.1073/pnas.94.19.10367]
80. Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler TW. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 2001; 98: 3410-3415 [PMID: 11248092 DOI:10.1073/pnas.051618798]
81. Oijen AH, Verhulst ML, Roelofs HM, Peters WH, de Boer WA, Jansen JB. Eradication of Helicobacter pylori restores glutathione S-transferase activity and glutathione levels in antral mucosa. Jpn J Cancer Res 2001; 92: 1329-1334 [PMID: 11749699 DOI: 10.1111/j.1349-7006.2001.tb02157.x]
82. Yanaka A, Fahey JW, Fukumoto A, Nakayama M, Inoue S, Zhang S, Tauchi M, Suzuki H, Hyodo I, Yamamoto M. Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans. Cancer Prev Res (Phila) 2009; 2: 353-360 [PMID: 19349290 DOI: 10.1158/1940-6207.CAPR-08-0192]
83. Basch E, Jia X, Heller G, Barz A, Sit L, Fruscione M, Appawu M, Iasonos A, Atkinson T, Goldfarb S, Culkin A, Kris MG, Schrag D. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst 2009; 101: 1624-1632 [PMID: 19920223 DOI: 10.1093/jnci/djp386]
84. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236 [PMID: 21685461 DOI: 10.3322/caac.20121]
85. Padidar S, Farquharson AJ, Williams LM, Kearney R, Arthur JR, Drew JE. High-fat diet alters gene expression in the liver and colon: links to increased development of aberrant crypt foci. Dig Dis Sci 2012; 57: 1866-1874 [PMID: 22373862 DOI: 10.1007/s10620-012-2092-9]
86. Park H, Kim M, Kwon GT, Lim do Y, Yu R, Sung MK, Lee KW, Daily JW, Park JH. A high-fat diet increases angiogenesis, solid tumor growth, and lung metastasis of CT26 colon cancer cells in obesity-resistant BALB/c mice. Mol Carcinog 2012; 51: 869-880 [PMID: 21919080 DOI: 10.1002/mc.20856]
87. Sung MK, Yeon JY, Park SY, Park JH, Choi MS. Obesity-induced metabolic stresses in breast and colon cancer. Ann NY Acad Sci 2011; 1229: 61-68 [PMID: 21793840 DOI:10.1111/j.1749-6632.2011.06094.x]
88. Tang FY, Pai MH, Chiang EP. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model. J Nutr Biochem 2012; 23: 1302-1313 [PMID: 22221675 DOI: 10.1016/j.jnutbio.2011.07.011]
89. Herbst A, Kolligs FT. Wnt signaling as a therapeutic target for cancer. Methods Mol Biol 2007; 361: 63-91 [PMID: 17172707]
90. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-1512 [PMID: 9727977 DOI: 10.1126/science.281.5382.1509]
91. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-426 [PMID: 10201372 DOI: 10.1038/18884]
92. Liu Z, Brooks RS, Ciappio ED, Kim SJ, Crott JW, Bennett G, Greenberg AS, Mason JB. Diet-induced obesity elevates colonic TNF-α in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity-associated colorectal cancer. J Nutr Biochem 2012; 23: 1207-1213 [PMID: 22209007 DOI: 10.1016/j.jnutbio.2011.07.002]
93. Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD, Le Marchand L, Green RC, Parfrey P, Younghusband HB, Cotterchio M, Gallinger S, Jenkins MA, Hopper JL, Baron JA, Thibodeau SN, Lindor NM, Limburg PJ, Martínez ME. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 2010; 102: 391-400 [PMID: 20208017 DOI: 10.1093/jnci/djq011]
94. Key TJ, Spencer EA, Reeves GK. Symposium 1: Overnutrition: consequences and solutions. Obesity and cancer risk. Proc Nutr Soc 2010; 69: 86-90 [PMID: 19954565 DOI: 10.1017/ S0029665109991698]
95. Chen J. Multiple signal pathways in obesity-associated cancer. Obes Rev 2011; 12: 1063-1070 [PMID: 22093240 DOI: 10.1111/j.1467-789X.2011.00917.x]
96. Chen A, Xu J, Johnson AC. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 2006; 25: 278-287 [PMID: 16170359 DOI: 10.1038/sj.onc.1209019]
97. Patel BB, Gupta D, Elliott AA, Sengupta V, Yu Y, Majumdar AP. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. Anticancer Res 2010; 30: 319-325 [PMID: 20332435]
98. Lee YK, Park SY, Kim YM, Park OJ. Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Ann NY Acad Sci 2009; 1171: 489-494 [PMID: 19723094 DOI: 10.1111/j.1749-6632. 2009.04699.x]
99. Binion DG, Otterson MF, Rafiee P. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut 2008; 57: 1509-1517 [PMID: 18596194 DOI: 10.1136/ gut.2008.152496]
100. Ryu MJ, Cho M, Song JY, Yun YS, Choi IW, Kim DE, Park BS, Oh S. Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun 2008; 377: 1304-1308 [PMID: 19000900]
101. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235-237 [PMID: 1528264 DOI: 10.1038/359235a0]
102. Jaiswal AS, Marlow BP, Gupta N, Narayan S. Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 2002; 21: 8414-8427 [PMID: 12466962 DOI: 10.1038/ sj.onc.1205947]
103. Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 2010; 70: 7392-7399 [PMID: 20841478 DOI: 10.1158/0008-5472.CAN-10-20270008-5472. CAN-10-2027]
104. Nguyen AV, Martinez M, Stamos MJ, Moyer MP, Planutis K, Hope C, Holcombe RF. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res 2009; 1: 25-37 [PMID: 21188121]
105. Cui X, Jin Y, Hofseth AB, Pena E, Habiger J, Chumanevich A, Poudyal D, Nagarkatti M, Nagarkatti PS, Singh UP, Hofseth LJ. Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Prev Res (Phila) 2010; 3: 549-559 [PMID: 20332304 DOI: 10.1158/1940-6207.CAPR-09-0117]
106. Sengottuvelan M, Deeptha K, Nalini N. Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis. Chem Biol Interact 2009; 181: 193-201 [PMID: 19523937 DOI: 10.1016/j.cbi.2009.06.004]
107. Sengottuvelan M, Nalini N. Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-di-methylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development. Br J Nutr 2006; 96: 145-153 [PMID: 16870003]
108. LeRoith D, Roberts CT. The insulin-like growth factor system and cancer. Cancer Lett 2003; 195: 127-137 [PMID: 12767520]
109. Vanamala J, Radhakrishnan S, Reddivari L, Bhat VB, Ptitsyn A. Resveratrol suppresses human colon cancer cell proliferation and induces apoptosis via targeting the pentose phosphate and the talin-FAK signaling pathways-A proteomic approach. Proteome Sci 2011; 9: 49 [PMID: 21849056]
110. Hwang JT, Kwak DW, Lin SK, Kim HM, Kim YM, Park OJ. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway. Ann NY Acad Sci 2007; 1095: 441-448 [PMID: 17404056]